Renaissance Technologies
GMVD

Renaissance Technologies’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Renaissance Technologies’s Portfolio GMVD Stock Details GMVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,916
Closed -$4K – 4287
2023
Q2 		$4K Buy
+10,916
New +$4.92K ﹤0.01% 3856

Other funds holding GMVD

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies's GMVD Position: Q3 2023 in Review

Renaissance Technologies sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q3 2023, closing a stake of 10,916 shares — an estimated $4K sold.

Renaissance Technologies first reported a position in GMVD in Q2 2023 and held it in 1 quarter. The position peaked at $4K in Q2 2023. 3 funds tracked by Wall St. Rank hold GMVD as of Q3 2023.

  • Renaissance Technologies reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 10,916 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q3 2023, an estimated $4K.
  • Renaissance Technologies first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q2 2023 and held it in 1 quarter.
  • Renaissance Technologies's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $4K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.